Skip to main content
Clinical Trials/NCT03213028
NCT03213028
Completed
N/A

Family Planning Service Delivery Integration For HIV Positive And At-Risk Women In Botswana: A Hybrid Type 2 Clinical Intervention And Implementation Strategy

University of Pennsylvania1 site in 1 country248 target enrollmentAugust 18, 2017
ConditionsFamily Planning

Overview

Phase
N/A
Intervention
Not specified
Conditions
Family Planning
Sponsor
University of Pennsylvania
Enrollment
248
Locations
1
Primary Endpoint
Provider rating of feasibility
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The goal of this pilot study is to assess both implementation outcomes (acceptability, feasibility and adoption) and clinical efficacy (contraceptive method uptake by women wishing to avoid pregnancy) using a Hybrid Type 2 study design of a family planning program being piloted by the Cervical Cancer Prevention Program in Gabarone, Botswana.

Registry
clinicaltrials.gov
Start Date
August 18, 2017
End Date
August 10, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • English or Setswana speaking
  • Receiving CCP services at the clinic
  • 18-45 years of age
  • Able to give informed consent to study procedures, as determined by research/clinic staff

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Provider rating of feasibility

Time Frame: 6 months

Likert scale 1-5, rating feasibility of offering family planning in this clinical setting

Provider report of adoption of the intervention

Time Frame: 6 months

Comparing number of family planning methods offered by a provider pre- and post-intervention

Provider acceptability rating

Time Frame: 6 months

Likert scale 1-5, rating acceptability of offering family planning in this clinical setting.

Study Sites (1)

Loading locations...

Similar Trials